Serum and plasma BDNF levels in major depression: a replication study and meta-analyses - PubMed (original) (raw)
Meta-Analysis
Serum and plasma BDNF levels in major depression: a replication study and meta-analyses
Luisella Bocchio-Chiavetto et al. World J Biol Psychiatry. 2010 Sep.
Abstract
Objectives: Alterations of BDNF signalling in major depression (MD) are supported by studies demonstrating decreased levels of the neurotrophin serum and plasma content in MD patients. We conducted a replication study and we performed two meta-analyses on studies analysing serum and plasma BDNF levels in MD patients.
Methods: The samples were composed by 489 patients/483 controls for the meta-analysis on serum and by 161 patients/211 controls for that on plasma levels. We performed also subgroup analyses to examine whether the decrease in BDNF levels in MD was influenced by gender.
Results: In the replication study we found decreased serum BDNF levels in MD patients (P<0.01) and we demonstrated that is down-regulated the mature form of the neurotrophin (mBDNF). No significant difference was evidenced for plasma BDNF levels. The meta-analyses showed a reduction of both BDNF serum (P<0.0001) and plasma levels (P=0.02) in MD. No difference in the effect size on serum BDNF was observed between males and females (P=0.18).
Conclusions: In conclusion, our results provide evidence of peripheral BDNF alteration in MD and support the rationale for further investigation aiming to the identification of biomarkers for differential diagnosis and personalization of therapies in this disorder.
Similar articles
- Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.
Sen S, Duman R, Sanacora G. Sen S, et al. Biol Psychiatry. 2008 Sep 15;64(6):527-32. doi: 10.1016/j.biopsych.2008.05.005. Epub 2008 Jun 24. Biol Psychiatry. 2008. PMID: 18571629 Free PMC article. - BDNF and pro-BDNF in serum and exosomes in major depression: Evolution after antidepressant treatment.
Gelle T, Samey RA, Plansont B, Bessette B, Jauberteau-Marchan MO, Lalloué F, Girard M. Gelle T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110229. doi: 10.1016/j.pnpbp.2020.110229. Epub 2020 Dec 31. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33358963 - Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M, Hashimoto K. Yoshida T, et al. PLoS One. 2012;7(8):e42676. doi: 10.1371/journal.pone.0042676. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22880079 Free PMC article. - BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML. Polyakova M, et al. J Affect Disord. 2015 Mar 15;174:432-40. doi: 10.1016/j.jad.2014.11.044. Epub 2014 Nov 29. J Affect Disord. 2015. PMID: 25553404 Review. - Association of Peripheral Blood Levels of Brain-Derived Neurotrophic Factor With Autism Spectrum Disorder in Children: A Systematic Review and Meta-analysis.
Qin XY, Feng JC, Cao C, Wu HT, Loh YP, Cheng Y. Qin XY, et al. JAMA Pediatr. 2016 Nov 1;170(11):1079-1086. doi: 10.1001/jamapediatrics.2016.1626. JAMA Pediatr. 2016. PMID: 27654278 Review.
Cited by
- Investigating Neuroplasticity Changes Reflected by BDNF Levels in Astrocyte-Derived Extracellular Vesicles in Patients with Depression.
Li K, Wang K, Xu SX, Xie XH, Tang Y, Zhang L, Liu Z. Li K, et al. Int J Nanomedicine. 2024 Sep 2;19:8971-8985. doi: 10.2147/IJN.S477482. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39246428 Free PMC article. - Plasma Neurotrophic Factor Levels are not Associated with the Severity of Depression: Prospective Pilot Study.
Zorkina YA, Syunyakov TS, Abramova OV, Yunes RA, Pavlichenko AV, Pavlov KA, Khobta EB, Susloparova DA, Tsarapkin GY, Andreyuk DS, Danilenko VN, Gurina OI, Morozova AY. Zorkina YA, et al. Consort Psychiatr. 2021 Dec 31;2(4):13-22. doi: 10.17816/CP110. eCollection 2021. Consort Psychiatr. 2021. PMID: 39045452 Free PMC article. - Sex-dependent associations of serum BDNF, glycolipid metabolism and cognitive impairments in Parkinson's disease with depression: a comprehensive analysis.
Wang X, Zhou C, Li Y, Yang H, Sun X, Li S, Li J. Wang X, et al. J Neural Transm (Vienna). 2024 Sep;131(9):1047-1057. doi: 10.1007/s00702-024-02802-1. Epub 2024 Jul 5. J Neural Transm (Vienna). 2024. PMID: 38967809 - Current Methodological Pitfalls and Caveats in the Assessment of Exercise-Induced Changes in Peripheral Brain-Derived Neurotrophic Factor: How Result Reproducibility Can Be Improved.
Nicolini C, Nelson AJ. Nicolini C, et al. Front Neuroergon. 2021 May 28;2:678541. doi: 10.3389/fnrgo.2021.678541. eCollection 2021. Front Neuroergon. 2021. PMID: 38235217 Free PMC article. Review. - The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy.
AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GE. AlRuwaili R, et al. Neurochem Res. 2024 Mar;49(3):533-547. doi: 10.1007/s11064-023-04064-x. Epub 2023 Nov 25. Neurochem Res. 2024. PMID: 38006577 Free PMC article. Review.